Pyroglutamic acid: Throwing light on a lightly studied metabolite

Current Science

Volumn 102, Issue 2, 2012, Pages 288-297

  Kumar, Akhilesh ^a   Bachhawat, Anand K ^b  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

Author keywords

Glutamyl cycle; 5 oxoproline; 5 oxoprolinuria; Neuronal peptides; Pyroglutamic acid

Indexed keywords

EID: 84864826447     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Haitinger, L., Vorlauge Mittheilung iiber Glutaminsaure und Pyrrol. Monatsh. Chem., 1882, 3, 228-229.
2. Connell, G. E. and Hanes, C. S., Enzymic formation of pyrrolidone carboxylic acid from gamma-glutamyl peptides. Nature, 1956, 177, 377-378.
3. Woodward, G. E. and Reinhart, F. E., The effect of pH on the formation of pyrrolidonecarboxylic acid and glutamic acid during enzymic hydrolysis of glutathione by rat-kidney extract. J. Biol. Chem., 1942, 145, 471-480.
4. Van der Werf, P., Orlowski, M. and Meister, A., Enzymatic conversion of 5-oxo- L-proline (L-pyrrolidone carboxylate) to Lglutamate coupled with cleavage of adenosine triphosphate to adenosine diphosphate, a reaction in the -glutamyl cycle. Proc. Natl. Acad. Sci. USA, 1971, 68, 2982-2985.
5. Meister, A., On the enzymology of amino acid transport. Science, 1973, 180, 33-39.
6. Moret, C. and Briley, M., The 'forgotten' amino acid pyroglutamate. Trends Pharmacol. Sci., 1988, 9, 278-279.
7. Christensen, H. N., Amino acids are not un-charged (lipid-soluble) substances. Why we might as well forget pyroglutamate as an amino acid. Trends Pharmacol. Sci., 1988, 9, 430.
8. Garattini, S., Glutamic acid, twenty years later. J. Nutr., 2000, 130, 901S-909S.
9. Orlowski, M., Richman, P. G. and Meister, A., Isolation and properties of gamma-L-glutamylcyclotransferase from human brain. Biochemistry, 1969, 8, 1048-1055.
10. Oakley, A. J., Yamada, T., Liu, D., Coggan, M., Clark, A. G. and Board, P. G., The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle. J. Biol. Chem., 2008, 283, 22031-22042.
11. Ye, G. J., Breslow, E. B. and Meister, A., The amino acid sequence of rat kidney 5-oxo-L-prolinase determined by cDNA cloning. J. Biol. Chem., 1996, 271, 32293-32300.
12. Kumar, A. and Bachhawat, A. K., OXP1/YKL215c encodes an ATP-dependent 5-oxoprolinase in Saccharomyces cerevisiae: functional characterization, domain structure and identification of actin-like ATP-binding motifs in eukaryotic 5-oxoprolinases. FEMS Yeast Res., 2010, 10, 394-401.
13. van der Werf, P. and Meister, A., The metabolic formation and utilization of 5-oxo-L-proline (L-pyroglutamate, L-pyrrolidone carboxylate). Adv. Enzymol. Relat. Areas Mol. Biol., 1975, 43, 519-556.
14. Adamson, E. D., Szewczuk, A. and Connell, G. E., Purification and properties of gamma-glutamyl cyclotransferase from pig liver. Can. J. Biochem., 1971, 49, 218-226.
15. Board, P. G., Moore, K. A. and Smith, J. E., Purification and properties of gamma-glutamylcyclotransferase from human erythrocytes. Biochem. J., 1978, 173, 427-431.
16. Orlowski, M. and Meister, A., -Glutamyl cyclotransferase. Distribution, isozymic forms, and specificity. J. Biol. Chem., 1973, 248, 2836-2844.
17. Llewellyn, N. M., Li, Y. and Spencer, J. B., Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain. Chem. Biol., 2007, 14, 379-386.
18. Krishnaswamy, P. R., Pamiljans, V. and Meister, A., Activated glutamate intermediate in the enzymatic synthesis of glutamine. J. Biol. Chem., 1960, 235, PC39-PC40.
19. Orlowski, M. and Meister, A., Partial reactions catalyzed by glutamylcysteine synthetase and evidence for an activated glutamate intermediate. J. Biol. Chem., 1971, 246, 7095-7105.
20. Seddon, A. P., Zhao, K. Y. and Meister, A., Activation of glutamate by gamma-glutamate kinase: formation of gamma-ciscycloglutamyl phosphate, an analog of gamma-glutamyl phosphate. J. Biol. Chem., 1989, 264, 11326-11335.
21. Katchalsky, A. and Paecht, M., Phosphate anhydrides of amino acids. J. Am. Chem. Soc., 1954, 76, 6042-6044.
22. Khmelenina, V. N., Kalyuzhnaya, M. G., Sakharovsky, V. G., Suzina, N. E., Trotsenko, Y. A. and Gottschalk, G., Osmoadaptation in halophilic and alkaliphilic methanotrophs. Arch. Microbiol., 1999, 172, 321-329.
23. Rush, E. A. and Starr, J. L., The indirect incorporation of pyrrolidone carboxylic acid into transfer ribonucleic acid. Biochim. Biophys. Acta, 1970, 199, 41-55.
24. Schilling, S., Hoffmann, T., Manhart, S., Hoffmann, M. and Demuth, H. U., Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions. FEBS Lett., 2004, 563, 191-196.
25. Cummins, P. M. and O'Connor, B., Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim. Biophys. Acta, 1998, 1429, 1-17.
26. Van der Werf, P., Griffith, O. W. and Meister, A., 5-Oxo-Lprolinase (L-pyroglutamate hydrolase). Purification and catalytic properties. J. Biol. Chem., 1975, 250, 6686-6692.
27. Griffith, O. W. and Meister, A., 5-Oxo-L-prolinase (L-pyroglutamate hydrolase). Studies of the chemical mechanism. J. Biol. Chem., 1981, 256, 9981-9985.
28. Seddon, A. P. and Meister, A., Trapping of an intermediate in the reaction catalyzed by 5-oxoprolinase. J. Biol. Chem., 1986, 261, 11538-11543.
29. Nishimura, A., Ozaki, Y., Oyama, H., Shin, T. and Murao, S., Purification and characterization of a novel 5-oxoprolinase (without ATP-hydrolyzing activity) from Alcaligenes faecalis N-38A. Appl. Environ. Microbiol., 1999, 65, 712-717.
30. Nishimura, A., Oyama, H., Hamada, T., Nobuoka, K., Shin, T., Murao, S. and Oda, K., Molecular cloning, sequencing, and expression in Escherichia coli of the gene encoding a novel 5- oxoprolinase without ATP-hydrolyzing activity from Alcaligenes faecalis N-38A. Appl. Environ. Microbiol., 2000, 66, 3201-3205.
31. Ramakrishna, M. and Krishnaswamy, P. R., A paper chromatographic method for identification and estimation of pyrrolidonecarboxylic acid. Anal. Biochem., 1967, 19, 338-343.
32. Mochizuki, K., Purification and characterization of 5-oxo-Lprolinase from Paecilomyces varioti F-1, an ATP-dependent hydrolase active with L-2-oxothiazolidine-4-carboxylic acid. Arch. Microbiol., 1999, 172, 182-185.
33. Weber, P., Jager, M., Bangsow, T., Knell, G., Piechaczek, K., Koch, J. and Wolf, S., Kinetic parameters and tissue distribution of 5-oxo-L-prolinase determined by a fluorimetric assay. J. Biochem. Biophys. Methods, 1999, 38, 71-82.
34. Watanabe, T., Abe, K., Ishikawa, H. and Iijima, Y., Bovine 5-oxo- L-prolinase: simple assay method, purification, cDNA cloning, and detection of mRNA in the coronary artery. Biol. Pharm. Bull., 2004, 27, 288-294.
35. Fietzek, P. P., Breitkreutz, D. and Kuhn, K., Amino acid sequence of the amino-terminal region of calf skin collagen. Biochim. Biophys. Acta, 1974, 365, 305-310.
36. Lopez-Vera, E. et al., Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J., 2007, 274, 3972-3985.
37. Mandal, A. K., Ramasamy, M. R., Sabareesh, V., Openshaw, M. E., Krishnan, K. S. and Balaram, P., Sequencing of T-superfamily conotoxins from Conus virgo: pyroglutamic acid identification and disulfide arrangement by MALDI mass spectrometry. J. Am. Soc. Mass. Spectrom., 2007, 18, 1396-1404.
38. Mandal, A. K. and Balaram, P., Mass spectrometric identification of pyroglutamic acid in peptides following selective hydrolysis. Anal. Biochem., 2007, 370, 118-120.
39. Blaszczyk, J. et al., Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry, 2000, 39, 14075-14081.
40. Boler, J., Enzmann, F., Folkers, K., Bowers, C. Y. and Schally, A. V., The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. Biophys. Res. Commun., 1969, 37, 705-710.
41. Carraway, R. and Leeman, S. E., The amino acid sequence of a hypothalamic peptide, neurotensin. J. Biol. Chem., 1975, 250, 1907-1911.
42. Van Coillie, E. et al., Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry, 1998, 37, 12672-12680.
43. Hinkle, P. M. and Tashjian Jr, A. H., Receptors for thyrotropinreleasing hormone in prolactin producing rat pituitary cells in culture. J. Biol. Chem., 1973, 248, 6180-6186.
44. Perlman, J. H., Thaw, C. N., Laakkonen, L., Bowers, C. Y., Osman, R. and Gershengorn, M. C., Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. J. Biol. Chem., 1994, 269, 1610-1613.
45. Lou, Y. C., Huang, Y. C., Pan, Y. R., Chen, C. and Liao, Y. D., Roles of N-terminal pyroglutamate in maintaining structural integrity and pKa values of catalytic histidine residues in bullfrog ribonuclease 3. J. Mol. Biol., 2006, 355, 409-421.
46. Chelius, D. et al., Formation of pyroglutamic acid from Nterminal glutamic acid in immunoglobulin gamma antibodies. Anal. Chem., 2006, 78, 2370-2376.
47. Liu, Y. D., Goetze, A. M., Bass, R. B. and Flynn, G. C., Nterminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies. J. Biol. Chem., 2011, 286, 11211-11217.
48. Wirths, O., Breyhan, H., Cynis, H., Schilling, S., Demuth, H. U. and Bayer, T. A., Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol., 2009, 118, 487-496.
49. Tomidokoro, Y. et al., Pyroglutamate formation at the N-termini of Abri molecules in familial British Dementia is not restricted to the central nervous system. Hirosaki. Igaku, 2010, 61, S262-S269.
50. Schlenzig, D. et al., Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry, 2009, 48, 7072-7078.
51. Schilling, S. et al., Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nature Med., 2008, 14, 1106-1111.
52. Jawhar, S., Wirths, O., Schilling, S., Graubner, S., Demuth, H. U. and Bayer, T. A., Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. J. Biol. Chem., 2011, 286, 4454-4460.
53. Caccia, S., Garattini, S., Ghezzi, P. and Zanini, M. G., Plasma and brain levels of glutamate and pyroglutamate after oral monosodium glutamate to rats. Toxicol. Lett., 1982, 10, 169-175.
54. Chanal, J. L., Audran, M., Sicard, M. T. and Briley, M., Brain penetration of orally administered sodium pyroglutamate. J. Pharm. Pharmacol., 1988, 40, 584-585.
55. Drago, F., Valerio, C., D'Agata, V., Astuto, C., Spadaro, F., Continella, G. and Scapagnini, U., Pyroglutamic acid improves learning and memory capacities in old rats. Funct. Neurol., 1988, 3, 137-143.
56. Miyauchi, S. et al., Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter. Biochim. Biophys. Acta, 2010, 1798, 1164-1171.
57. Dusticier, N., Kerkerian, L., Errami, M. and Nieoullon, A., Effects of pyroglutamic acid on corticostriatal glutamatergic transmission. Neuropharmacology, 1985, 24, 903-908.
58. Oono, S. et al., Pyroglutamic acid promotes survival of retinal ganglion cells after optic nerve injury. Curr. Eye Res., 2009, 34, 598-605.
59. Hawkins, R. A., Simpson, I. A., Mokashi, A. and Vina, J. R., Pyroglutamate stimulates Na+-dependent glutamate transport across the blood-brain barrier. FEBS Lett., 2006, 580, 4382-4386.
60. Lee, W. J., Hawkins, R. A., Peterson, D. R. and Vina, J. R., Role of oxoproline in the regulation of neutral amino acid transport across the blood-brain barrier. J. Biol. Chem., 1996, 271, 19129-19133.
61. Vina, J. R., Puertes, I. R., Montoro, J. B., Saez, G. T. and Vina, J., Gamma-glutamyl-amino acids as signals for the hormonal regulation of amino acid uptake by the mammary gland of the lactating rat. Biol. Neonate, 1985, 48, 250-256.
62. Vina, J. R., Palacin, M., Puertes, I. R., Hernandez, R. and Vina, J., Role of the gamma-glutamyl cycle in the regulation of amino acid translocation. Am. J. Physiol., 1989, 257, E916-E922.
63. Borg, J., Stenger, A. and Toazara, J., Uptake and metabolism of l-[(3)H]pyroglutamic acid in neuronal and glial cells in culture. Neurochem. Int., 1986, 8, 397-402.
64. Koga, M. et al., Glutathione is a physiologic reservoir of neuronal glutamate. Biochem. Biophys. Res. Commun., 2011, 409, 596-602.
65. Ohkama-Ohtsu, N., Oikawa, A., Zhao, P., Xiang, C., Saito, K. and Oliver, D. J., A gamma-glutamyl transpeptidase-independent pathway of glutathione catabolism to glutamate via 5-oxoproline in Arabidopsis. Plant Physiol., 2008, 148, 1603-1613.
66. Rucktooa, P. et al., Crystal structures of two Bordetella pertussis periplasmic receptors contribute to defining a novel pyroglutamic acid binding DctP subfamily. J. Mol. Biol., 2007, 370, 93-106.
67. Trotsenko Iu, A. and Khelenina, V. N., The biology and osmoadaptation of haloalkaliphilic methanotrophs. Mikrobiologiia, 2002, 71, 149-159.
68. Mucchetti, G., Locci, F., Gatti, M., Neviani, E., Addeo, F., Dossena, A. and Marchelli, R., Pyroglutamic acid in cheese: presence, origin, and correlation with ripening time of Grana Padano cheese. J. Dairy Sci., 2000, 83, 659-665.
69. Ponnusamy, K., Choi, J. N., Kim, J., Lee, S. Y. and Lee, C. H., Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J. Med. Microbiol., 2011, 60, 817-827.
70. Marstein, S., Jellum, E. and Eldjarn, L., The concentration of pyroglutamic acid (2-pyrrolidone-5-carboxylic acid) in normal and psoriatic epidermis, determined on a microgram scale by gas chromatography. Clin. Chim. Acta, 1973, 49, 389-395.
71. Marstein, S., Studies on the accumulation of L-pyroglutamic acid in guinea pig epidermis. J. Invest. Dermatol., 1980, 74, 135-138.
72. Yoshinari, O. and Igarashi, K., Anti-diabetic effect of pyroglutamic acid in type 2 diabetic Goto-Kakizaki rats and KK-A y mice. Br. J. Nutr, 2011, 106, 1-10.
73. Castan-Laurell, I., Dray, C., Attane, C., Duparc, T., Knauf, C. and Valet, P., Apelin, diabetes, and obesity. Endocrine, 2011, 40, 1-9.
74. Ristoff, E. and Larsson, A., Inborn errors in the metabolism of glutathione. Orphanet. J. Rare Dis., 2007, 2, 16.
75. Wellner, V. P., Sekura, R., Meister, A. and Larsson, A., Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc. Natl. Acad. Sci. USA, 1974, 71, 2505-2509.
76. Snoke, J. E., Isolation and properties of yeast glutathione synthetase. J. Biol. Chem., 1955, 213, 813-824.
77. Richman, P. G. and Meister, A., Regulation of gamma-glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem., 1975, 250, 1422-1426.
78. Larsson, A. and Mattsson, B., On the mechanism of 5-oxoproline overproduction in 5-oxoprolinuria. Clin. Chim. Acta, 1976, 67, 245-253.
79. Dahl, N. et al., Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum. Mol. Genet., 1997, 6, 1147-1152.
80. Larsson, A., Mattsson, B., Wauters, E. A., van Gool, J. D., Duran, M. and Wadman, S. K., 5-Oxoprolinuria due to hereditary 5- oxoprolinase deficiency in two brothers -a new inborn error of the gamma-glutamyl cycle. Acta Paediatr. Scand., 1981, 70, 301-308.
81. Roesel, R. A., Hommes, F. A. and Samper, L., Pyroglutamic aciduria (5-oxoprolinuria) without glutathione synthetase deficiency and with decreased pyroglutamate hydrolase activity. J. Inherit. Metab. Dis., 1981, 4, 89-90.
82. Humphreys, B. D., Forman, J. P., Zandi-Nejad, K., Bazari, H., Seifter, J. and Magee, C. C., Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am. J. Kidney Dis., 2005, 46, 143-146.
83. Lawrence, D. T., Bechtel, L. K., Charlton, N. P. and Holstege, C. P., 5-Oxoproline-induced anion gap metabolic acidosis after an acute acetaminophen overdose. J. Am. Osteopath. Assoc., 2010, 110, 545-551.
84. Town, M. et al., A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet., 1998, 18, 319-324.
85. Levtchenko, E. N. et al., Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblasts. Pediatr. Res., 2006, 59, 287-292.
86. Rizzo, C., Ribes, A., Pastore, A., Dionisi-Vici, C., Greco, M., Rizzoni, G. and Federici, G., Pyroglutamic aciduria and nephropathic cystinosis. J. Inherit. Metab. Dis., 1999, 22, 224-226.
87. Mannucci, L., Pastore, A., Rizzo, C., Piemonte, F., Rizzoni, G. and Emma, F., Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts. Pediatr. Res., 2006, 59, 332-335.
88. Kumar, A. and Bachhawat, A. K., A futile cycle, formed between two ATP-dependant gamma-glutamyl cycle enzymes, gammaglutamyl cysteine synthetase and 5-oxoprolinase: the cause of cellular ATP depletion in nephrotic cystinosis? J. Biosci., 2010, 35, 21-25.